As oxidative stress and inflammation are known to have a role in the incidence of neurodegenerative diseases, the SIRT1/Nrf2/HO-1 pathway possesses an attractive target for the treatment of ADHD diseases. The gene discussed is HMOX1; the disease is attention deficit-hyperactivity disorder.